Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
0.6510
+0.0045 (0.70%)
Sep 18, 2025, 4:00 PM EDT - Market closed
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $14.16 million as of September 18, 2025. Its market cap has decreased by -5.12% in one year.
Market Cap
14.16M
Enterprise Value
7.74M
1-Year Change
-5.12%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from $3.58M to $14.16M, an increase of 295.48%. That is a compound annual growth rate of 7.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 14.16M | -8.98% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | 28.71M | 121.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |